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Background: -adrenoceptor antagonist celiprolol has been widely used as an effective antihypertensive agent. Some
studies reported that celiprolol enhances nitric oxide production. The purpose of the present study is to examine the
effects of celiprolol on vein graft intimal hyperplasia and endothelium-dependent nitric oxide (NO)-mediated relaxation.
Methods: Japanese white rabbits were randomized to a control group that was fed regular rabbit chow or to a celiprolol
group that was fed regular rabbit chow supplemented with 100 mg/body celiprolol sodium. The reversed jugular vein
was implanted into the carotid artery. At 2 and 4 weeks after the operation, vein grafts in both groups were harvested, and
intimal hyperplasia of the vein grafts was assessed. At 4 weeks after the operation, harvested vein grafts from both the
groups were examined on the endothelium-dependent relaxation by application of Ach and were examined to detect for
endothelial NO synthase (eNOS) expression and superoxide anion production.
Results: Celiprolol inhibited intimal hyperplasia of carotid interposition-reversed jugular vein grafts 4 weeks after
implantation (Intima/media index of celiprolol group, 0.48  0.01 vs control group, 1.07  0.08, P < .05) and
suppressed cell proliferation in the neointima 2 weeks after implantation. In addition, celiprolol significantly enhanced
endothelium-dependent NO-mediated relaxation in the vein graft with no change in eNOS expression and a reduction in
superoxide production.
Conclusions: These novel findings clearly demonstrate that -adrenoceptor antagonist celiprolol can suppress intimal
hyperplasia of the vein graft, which may be due to the enhancement of nitric oxide function through an inhibition of
superoxide production. These results strongly support the clinical usefulness of celiprolol administration for preventing
intimal hyperplasia of the vein graft after bypass grafting. (J Vasc Surg 2007;46:116-23.)
Clinical Relevance: Late graft failure caused by neointimal hyperplasia limits the efficacy of vein grafting. Various
treatments were examined to reduce neointimal hyperplasia, but a standard clinical treatment has not yet been
established. We report here the inhibitory effect of -adrenoceptor antagonist celiprolol on the development of vein graft
intimal hyperplasia. In addition, we demonstrate that celiprolol showed endothelium-dependent NO-mediated relax-
ation through an inhibition of superoxide production in vein graft. Because the clinical benefits and safety of celiprolol
have been established to a certain extent through long-term clinical usage, celiprolol may soon become available treatment
after vein bypass grafting.Surgical revascularization using autologous veins con-
tinues to be the most widely practiced therapy for periph-
eral arterial occlusive diseases and coronary artery bypass
grafting.1 However, late graft failure caused by either inti-
mal hyperplasia or a progression of the underlying athero-
sclerotic disease limits the efficacy of vein grafting.2,3 En-
dothelium modulates the underlying vascular smooth
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116muscle by releasing the potent vasodilator endothelium-
derived relaxing factor (EDRF),4 which has been identified
as nitric oxide (NO). Several studies have demonstrated the
importance of preserving the function of endothelium-
derived NO in autogenous vein graft.5-9 We have previ-
ously demonstrated a close relationship between the pre-
served function of NO and intimal hyperplasia in vein
grafts.6,10,11 Blockers of adrenergic -receptors (-block-
ers) are commonly administered to patients with coronary
heart disease, arrhythmias, hypertension, and some cases of
cardiopathy. They have also been approved as a therapy of
chronic heart failure. In hypertensive patients, it was found
that the -blocker celiprolol increases endothelial NO syn-
thase (eNOS) activity and decreases superoxide anion pro-
duction.12 Celiprolol up-regulates eNOS mRNA as well as
protein expression and improves cardiovascular remodeling
in hypertensive rats.13 Kakoki et al14 found that celiprolol
augmented endothelium vasodilation in rat aortas. Further-
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ies celiprolol acts on sites other than -adrenoceptor in
endothelial cells and produces vasodilation by way of an
activation of the NO-cGMP system, suggesting that this
-blocker may improve endothelial function in vein grafts.
However, there is no information regarding the effects of
-blockers on vein graft intimal hyperplasia. The present
study was therefore designed to determine whether oral
administration of the -adrenoceptor antagonist celiprolol
suppresses intimal hyperplasia of the vein graft, if so, we also
examined its effects on endothelium-dependent NO-medi-
ated relaxation, eNOS expression, and superoxide produc-
tion in vein grafts.
METHODS
Animals and chemicals. Celiprolol sodium was ob-
tained from Nippon Shinyaku Co, Ltd (Kyoto, Japan).
Male Japanese white rabbits (Nippon SLC, Hamamatsu,
Japan), each weighting 2.5 to 3.0 kg, were used in this
study. The rabbits were housed individually at 20  3°C
with free access to water. The animal experiments were fully
reviewed by the Committee of Ethics on Animal Experi-
ments from the Faculty of Medicine, Nagoya University
and were carried out under the Guidelines for Animal
Experiments in the Faculty of Medicine, Nagoya Univer-
sity. The study also was in conformance with the publica-
tion Guiding Principles for the Care and Use of Laboratory
Animals (publication No. NIH 80-23, revised 1985).
Drug administration. Rabbits were randomly di-
vided into a control group that was fed commercial rabbit
chow (CR3) (CLEA Japan Inc, Tokyo, Japan) and a celip-
rolol group that received CR3 with 100 mg /day celiprolol
sodium for each rabbit. This dose of celiprolol was judged
to be appropriate for maintaining the blood pressure.16
Feeding was restricted to 120 g/day. Celiprolol treatment
was started on the day of the operation and continued until
the end of the experiment. All the rabbits appeared to be
healthy throughout the course of study. The rabbits which
had half or less of oral intake were omitted.
Measure of blood pressure and heart rate. Blood
pressure and heart rate were measured at the thigh of the
hind limb in the celiprolol group at the time of the opera-
tion and 28 days after operation. All measurements were
made before the induction of anesthesia, when all hemody-
namic variables were stabilized. It has been reported that
there was no significant difference in systolic blood pressure
at the time of the operation and 4 weeks after operation in
the control group.17
Vein graft implantation. Carotid interposition-re-
versed jugular vein grafts were performed, as previously
described.10,18 Anesthesia was induced intramuscularly
with ketamine hydrochloride (50mg/kg) and xyradine (10
mg/kg) and maintained with the intravenous administra-
tion of ketamine hydrochloride (10 mg/kg) and xyradine
(10 mg/kg). After a longitudinal neck incision, the left
jugular vein and the left common carotid artery were ex-
posed. The branches of the jugular vein were ligated and an
approximately 3 cm segment of the jugular vein was takenfor the autologous reversed-vein graft. Graft harvesting was
completed with meticulous care to avoid injuring the graft
wall. The harvested graft was kept moistened in heparinized
saline (5 IU/mL) at room temperature.
The carotid artery was clamped at the proximal and the
distal ends, and it was cut and replaced with the harvested
autologous jugular vein. The vein graft was anastomosed in
a reversed end-to-end fashion with interrupted 8-0 mono-
filament sutures under a surgical microscope. The wound
was closed layer to layer.
Harvest of implanted grafts. At each time-point after
implantation of the autologous vein grafts, the vein grafts
were harvested under general anesthesia as previously de-
scribed.10,18 In brief, the graft was isolated and harvested
after systemic heparinization (200 IU/kg intravenously),
and the rabbits were sacrificed by an overdose of pentobar-
bital. The harvested vein graft was fixed with 4% formalde-
hyde at a pressure of 100 mm Hg for 30 minutes. The
perfused vein graft was immersed in the same fixative
overnight at room temperature. The middle portion of the
harvested graft was used for histologic study and immuno-
histochemistry. Each sample was embedded in paraffin and
cut into 5-m sections.
Assessment of intimal hyperplasia. Four weeks after
the operation, vein grafts in both groups (control group, n
 8 and celiprolol group, n  5) were harvested, and
intimal hyperplasia of the vein graft from both groups was
assessed as previously described.18 In brief, each section,
harvested 4 weeks after implantation, was stained with
either hematoxylin and eosin or the elastica van Gieson
method. Four sections were obtained from each vein graft.
The intimal hyperplasia was measured by MACSCOPE
(Mitani Co, Fukai, Japan) at eight randomly selected dif-
ferent views per section. The extent of intimal hyperplasia
was expressed as intima/ media index (intima thickness
divided by media thickness). The average of eight values
was considered to represent the intimal hyperplasia of the
section, and the average of the four sections was considered
to represent those of the graft.
Immunohistochemical staining for proliferative
activity. Two weeks after implantation, vein grafts in both
groups (control group, n  8 and celiprolol group, n  6)
were harvested. After blocking the endogenous peroxidase
activity with 0.5% hydrogen peroxide in methanol for 5
minutes at room temperature, the specimens were preincu-
bated with 10% goat serum in phosphate-buffered saline
(PBS) for 30 minutes. Sections were then incubated at
room temperature for 30 minutes with monoclonal anti-
bodies directed against proliferative cell nuclear antigen
(PCNA) (clone PC 10, 1:200 dilution) (DAKO Cytoma-
tion Inc, Carpenteria, Calif) or for over night with mono-
clonal antibodies against Ki-67 antigen (clone MIB-1,
1:100 dilution) (DAKO Cytomation Inc). The sections
were then treated with the DAKO Envision  System,
following the manufacturer’s instructions. To calculate the
positive index, eight high-power fields (400) per section
were selected randomly and positive cells and total cells
were counted in the neointima in a blinded manner. The
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number of cells in one section, and the average of the two
sections was then considered to represent those in one vein
graft. The number of positive cells divided by the total
number of cells of the vein graft was defined as the PCNA
or Ki-67 index, as previously described.10,18,19 We em-
ployed both methods of examining proliferative activity for
greater reliability.
Endothelium-dependent relaxation. Four weeks af-
ter implantation, vein grafts in both groups (control group,
n  7 and celiprolol group, n  8) were harvested. Vein
grafts were immediately excised and placed in Krebs solu-
tion of the following millimolar composition: Na 137.4;
K 5.9; Mg2 1.2; Ca2 2.5; HCO3
 15.5; H2PO4
 1.2;
Cl 134; glucose 11.5, and then cleaned by removal of
connective tissues. After each vein graft had been cut open
along its long axis using a small scissors, circularly cut strips
were carefully prepared so as not to damage the endothe-
lium.
Circularly cut strips (3.5 mm long, 1 mm wide) were
mounted horizontally in a small chamber and attached to a
strain gauge (AE801; SensoNor a.s, Horten, Norway),
allowing us to record isometric tension. The chamber with
capacity of 0.3 ml was continuously perfused with Krebs
solution at a flow rate of 1.5 ml/minute. The transducer
was connected to a carrier amplifier (AS2101; NEC- San-ei
Instruments, Tokyo, Japan), and the output signal was fed
into a Macintosh computer (Apple Co, Tokyo, Japan)
through an analogue-digital converter (MacLab; AD In-
struments Pty Ltd, Castle Hill, Australia). Drift was less
than 3 N per hour. The resting tension was adjusted to
obtain the maximum contraction in high K solution (128
mM). Each preparation was allowed to equilibrate for 1
hour before the start of the experiment.
Endothelium-dependent relaxation was induced by cu-
mulative application of acetylcholine (108-106 M) dur-
ing the contraction induced by prostaglandin F2 (PGF2).
Unless otherwise stated, the concentration of PGF2 used
was 5 M. For this set of experiments, the preparations
were first contracted with PGF2 and then, after a steady-
state contraction had been attained, acetylcholine was cu-
mulatively applied from low to high concentration. In
order to examine the effect of the NO synthase inhibitor
NG-nitro-L-arginine methyl ester (L-NAME) on acetylcho-
line (ACh)-induced relaxation in celiprolol group, the en-
dothelium-intact strips were treated with L-NAME for 60
minutes and then the concentration-dependent effect of
ACh (108-106 M) was examined in the presence of
PGF2 n L-NAME-treated strips. Under the conditions,
the concentration of PGF2 was reduced to 1 M so as to
adjust the amplitude of contraction before and after appli-
cation of L-NAME. In some strips of celiprolol-treated
rabbits, the endothelium were removed to examine
whether the ACh-induced relaxation is endothelium-de-
pendent or not.11,20
Immunohistochemical staining for eNOS. Endo-
thelium-intact vein grafts were fixed with 4% paraformalde-
hyde in 0.1 M phosphate buffer, pH 7.4, for 3 hours. Thestrips were then embedded in optimal cutting temperature
(OCT) compound (Tissue Tek; Sakura Finetechnical, To-
kyo, Japan) and frozen at80°C. Cryosections were cut at
4 m thickness on a cryostat (Microtome Cryostat HM
550; MICROM International GmbH, Walldorf, Ger-
many), then mounted on MAS-coated glass slides (Matsu-
nami Glass, Kishiwada, Japan) for immunohistochemistry.
After a washout with 0.01 M phosphate-buffered saline
(PBS) solution (10 mMNa2HPO4 and 250 mMNaCl, pH
7.6), the sections were incubated at 4°C overnight with
rabbit anti-bovine eNOS serum (1:300 dilution; Calbio-
chem Novabiochem Corporation, San Diego, Calif) as the
primary antibody. After the sections had been rinsed with
PBS, they were incubated with the secondary antibody
(Alexa Fluor 488 goat anti-rabbit IgG antibody; dilution
1:5000; Molecular Probes, Eugene, Ore, ) for 1 hour at
room temperature. After a further wash with PBS, the
fluorescence of Alexa Fluor 488 was detected by confocal-
laser scanning microscopy (LSM5 PASCAL; Carl Zeiss,
Jena, Germany). The acquisition of images from different
groups of rabbits was performed under identical condi-
tions. Fluorescent 12-bit images were acquired and then
analyzed using commercial software (LSM5 PASCAL), as
previously reported.21 The total fluorescence intensities
obtained from four areas (36 x 36 pixels square) in each
preparation were averaged, and this (ie, one value for each
value) was used for subsequent analysis.
Detection of the production of superoxide anion.
Dihydroethidium (Molecular Probes, Eugene, Ore), an
oxidative fluorescence dye, was used to detect superoxide-
anion production in vein grafts. Dihydroethidium is oxi-
dized by superoxide anion and converted to ethidium,
which binds irreversibly to DNA, producing bright red
fluorescence. Segments (3.5 mm long) of vein graft were
incubated in Krebs solution at 37°C for 2 hours. After
incubation, the segments were frozen in OCT compound.
Then, transverse sections (10 m thickness) cut on a cryo-
stat (Microtome Cryostat HM 550) were placed on MAS-
coated glass slides and incubated in a light protected cham-
ber at 37°C for 30 minutes with 2 M dihydroethidium.
Images were obtained by confocal-laser-scanning micros-
copy (LSM5 PASCAL). The excitation wavelength was
488 nm and emission fluorescence was detected through a
585 nm long-pass filter. Identical laser settings were used
for the acquisition of images from the various groups of
rabbits. Fluorescent 12-bit images were acquired and then
analyzed using commercial software (LSM5 PASCAL), as
previously reported.21 The total fluorescence intensities
obtained from four areas (36 x 36 pixels square) in each
value were averaged, and this (ie, one value for each value)
was used for subsequent analysis.
Statistical analysis. Stat View 5.0 (SAS Institute) soft-
ware was used for statistical calculations. All values are
expressed as means standard error of the mean (SEM). A
one-way analysis of variance (ANOVA) (followed by
Scheffé F test for post hoc analysis) or Student unpaired t
test with an F test was used for statistical analysis. Nonpara-
metric Mann-Whitney U tests were used for statistical
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Differences between groups were considered to be statisti-
cally significant when the P value was 	 .05.
RESULTS
All animals survived, and all vein grafts (n  44) were
patent until the time of harvest.
Blood pressure and heart rate. Blood pressure and
heart rate were measured at the time of the operation and
28 days after implantation in the celiprolol group (n  4).
There was no difference between the baseline and 28 days
in the celiprolol group (systolic pressure of the baseline:
121 3.7 mmHg, systolic pressure of: 28 days: 128 8.0
mm Hg; P 
 .05, diastolic pressure of the baseline: 67 
7.9 mm Hg, diastolic pressure after 28 days: 68  5.5 mm
Hg; P 
 .05, heart rate of the baseline: 266  14.8/min,
heart rate after 28 days: 258  55.3/min, P 
 .05)
Suppression of intimal hyperplasia of the vein graft
by celiprolol. Intimal hyperplasia developed in both
groups (control group, n 8 and celiprolol group, n 5),
but the degree of intimal thickness in the celiprolol group
(33.3 1.1 m) was significantly smaller than those in the
control group (72.9  10.0 m) (P 	 .05). The intima/
media index in the celiprolol group (0.48 0.01) was also
significantly smaller than those in the control group. (1.07
 0.08) (P 	 .05) (Fig 1).
Suppression of cell proliferative activity by
celiprolol. The PCNA index was measured by using vein
grafts harvested 2 weeks after implantation (control group
n 8 and celiprolol group n 6). The PCNA index of the
neointimal lesion was significantly smaller in the celiprolol
group (12.1  1.2 %) compared with the control group
(24.5  5.2 %) (P 	 .05) (Fig 2).
The Ki-67index was measured by using vein grafts
harvested 2 weeks after implantation (control group n  8
and celiprolol group n  6). The Ki-67 index of the
neointimal lesion was significantly smaller in the celiprolol
group (10.1  1.2 %) compared with the control group
(15.9  5.6 %) (P 	 .05) (Fig 3).
Contractile response to 128 mM K and PGF2 in
vein grafts. In vein graft preparations harvested 4 weeks
after implantation, 128 mM K and PGF2 (5 M) in-
duced a similar magnitude of contraction in both the two
groups of rabbits (Fig 4). The responses to 128 mM K
and PGF2were not significantly different between the two
groups (P 
.05).
Endothelium-dependent relaxation. ACh-induced
relaxation was assessed by using vein grafts harvested 4
weeks after implantation (control group, n  7 and celip-
rolol group, n  8). Vein grafts of the control group
showed almost no response to acetylcholine, whereas those
of the celiprolol group showed a significantly relaxation to
acetylcholine in a concentration- dependent manner (P 	
.05) (Fig 5, A). L-NAME abolished the ACh-induced re-
laxation in the endothelium-intact strips the celiprolol
group (P	 .05). The acetylcholine-induced relaxation was
not observed in the endothelium-denuded strips of the
celiprolol-treated rabbits. (P 	 .05) (Fig 5, B).Effect of celiprolol on the expression of eNOS. The
eNOS expression was measured by using vein grafts har-
vested 4weeks after implantation (control group, n 8 and
celiprolol group, n  9). Immunoreactive fluorescence
against eNOS was detected in the endothelial layer (Fig 6,
A). As for the fluorescence intensities (arbitrary units),
there was no significant difference in the fluorescence in-
tensity between the two groups (Fig 6, B).
Effect of celiprolol on the production of superoxide
anion. Superoxide production was measured by using vein
grafts harvested 4 weeks after implantation (control group,
n 8 and celiprolol group, n 9). Superoxide production
was estimated from ethidium fluorescence intensities. The
Fig 1. Effect of celiprolol on the development of intimal hyper-
plasia of the vein graft 4 weeks after operation. A, Microscopic
findings of the middle portion of an autologous vein graft from the
control group fed with normal rabbit chow and the celiprolol
group fed daily with special chow containing 100 mg/body celip-
rolol. Arrowheads indicate the internal elastic lamina (elastica van
Gieson staining; original magnification 400). B, Quantitative
analysis of intimal hyperplasia of vein grafts by random eight-point
measurement. The intimal thickness was significantly smaller in the
celiprolol group (n 5) than in the control group (n 8).C, The
intima/media index was also significantly smaller in the celiprolol
group (n  5) than in the control group (n  8). Results are
expressed as the mean  SEM,*P 	 .05 vs control.images shown in the two groups were taken under identical
JOURNAL OF VASCULAR SURGERY
July 2007120 Hattori et alconditions. Superoxide production was found mainly in
endothelial layers (Fig 7, A), and was significantly lower in
preparations from the celiprolol rabbits (compared with
those from the control rabbits, Fig 7, B).
DISCUSSION
We have demonstrated that the -adrenergic blocker
celiprolol inhibits vein graft intimal hyperplasia through
suppression of the proliferative activity in the neointima of
rabbit. We also found that celiprolol enhanced endotheli-
um- dependent NO-mediated relaxation. To our knowl-
edge, this is the first study to report the beneficial effects of
-adrenergic blockers on endothelium-dependent relax-
ation and intimal hyperplasia in vein grafts.
Intimal thickening of autologous vein grafts is the
major cause of late graft failure.2, 3 Implantation of a vein
Fig 2. Effects of celiprolol on proliferative activity of the vein
graft neointima. The proliferative cell nuclear antigen (PCNA)
index was measured by using vein grafts harvested 2 weeks after
implantation. Counterstaining was done lightly with hematoxylin.
A, Microscopic findings with PCNA staining of the middle portion
of an autologous vein graft from the control group and the
celiprolol group. Arrowheads show PCNA-positive cells in the
neointima (original magnification400). B, Quantitative analysis
of the frequency of PCNA-positive cells. The PCNA index, the
number of PCNA-positive cells divided by the number of total
cells, was significantly suppressed in the celiprolol group (n  6)
compared with the control group (n 8). Results are expressed as
the mean  SEM, *P 	 .05 vs control.graft in the arterial circulation induces various changes thatmay lead to intimal hyperplasia, such as increased sheer
stress, loss of endothelial cells, migration and invasion of
inflammatory cells, and migration and proliferation of vas-
cular smooth muscle cells (VSMCs).22,23 We previously
reported that pronounced intimal thickening of a vein graft
was associated with impairment of endothelium-dependent
NO-mediated relaxation and increase in cell proliferative
activity of the neointima.6,24 Various treatments were ex-
amined to reduce intimal hyperplasia of vein grafts,10, 25
but standard clinical treatment has not yet been established.
We report here, for the first time, the inhibitory effect of
celiprolol on the development of vein graft intimal hyper-
plasia in vivo. -blockers are commonly administered in
cardiology for coronary heart disease, arrhythmias, hyper-
tension, and some cardiopathic treatment. The vasodilating
action of celiprolol is considered to be endothelium depen-
dent in part. However, the precise molecular mechanisms
are not fully clarified. Kakoki et al14 suggested that in rat
aorta, celiprolol might act on the 5-hydroxytryptamine
Fig 3. Effects of celiprolol on proliferative activity of the vein
graft neointima. The Ki-67 index was measured by using vein
grafts harvested 2 weeks after implantation. Counterstaining was
done lightly with hematoxylin.A, Microscopic findings with Ki-67
staining of the middle portion of an autologous vein graft from
control group and the celiprolol group. Arrowheads show Ki-67-
positive cells in the neointima (original magnification 400). B,
Quantitative analysis of the frequency of Ki-67-positive cells. The
Ki-67 index, the number of Ki-67-positive cells divided by the
number of total cells, was significantly suppressed in the celiprolol
group (n  6) compared with the control group (n  8). Results
are expressed as the mean  SEM, *P 	 .05 vs control.(5-HT1A) receptor on endothelial cells and produces a
between the two groups.
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ated by treatment with a 5-HT1A receptor antagonists.
Noda et al 15 suggested that in porcine coronary arteries,
celiprolol acts on sites other than -adrenoceptor in endo-
thelial cells and produces vasodilation by way of an activa-
tion of the NO-cGMP system. In the present study, we
found that oral administration of celiprolol enhances ACh-
induced endothelium-dependent NO-mediated relaxation
in vein grafts, as the relaxation was abolished by removal of
endothelium and by application of the NO synthase inhib-
itor L-NAME. Furthermore, this is unlikely due to indirect
effects mediated by a decrease in blood pressure, which is
expected when -blockers are chronically administrated,
since celiprolol (at the dose used in the present experi-
ments) did not significantly modify blood pressure.
Some works have suggested the existence of some
relationship between graft failure and the loss of endothe-
lium-dependent relaxation in reversed vein grafts.5-9, 26 We
previously demonstrated a relationship between reduced
production of endothelium derived NO and intimal hyper-
Fig 4. Effects of celiprolol on the contraction induced high K
(128 mM) and PGF2 in vein graft strips. High K
- induced
contraction (control rabbit: 8.8 2.1 mg, n 7, celiprolol rabbit:
6.8  2.3 mg, n  8; P  0.40) and PGF2- induced contraction
(control group: 5.1  2.3 mg, n  7, celiprolol group: 5.6  2.7
mg, n  8; P  0.66) were comparable between the two groups.
There were no statistically significant differences between high
K-induced contraction and the PGF2- induced contraction in
each group (P .25 in control group, P .74 in celiprolol group).
Data are shown as means and SEM.plasia in experimental autologous vein grafts.6 Further-Fig 5. Effects of celiprolol on endothelium-dependent relaxation
in response to ACh in the strip of vein graft harvested 4 weeks after
implantation from control group (n 7) and celiprolol group (n
8). A, ACh (10-8 to 10-6 mol/l) were cumulatively applied during
a contraction induced by PGF2 (5 x 10
-6 mol/l). The amplitude
of maintained tonic contraction induced by PGF2 before applica-
tion of ACh was normalized as a relative tension of 1.0 for strip.
The vein graft in control group showed no response, whereas a
dose-dependent relaxation in response to ACh was observed in the
celiprolol group (P 	 .001). B, The application of L-NAME
completely abolished endothelium- dependent relaxation in the
celiprolol group (n 4) (P	 .001). Vein grafts without endothe-
lium showed no response to acetylcholine in the celiprolol group
(n 4) (P	 .001). The PGF2 (5 M)- induced contraction with
endothelium before L-NAME application (1.4  0.4 mg, n  4)
and the PGF2 (1 M)- induced contraction with endothelium in
the presence of L-NAME (1.9  0.7 mg, n  4) were comparable
(P  0.58). The PGF2 (5 M)- induced contraction with endo-
thelium before L-NAME application and the PGF2 (3 M)-
induced contraction without endothelium (3.9  1.3 mg, n  4)
were comparable (P  0.12). Data are shown as means and SEM.
Asterisks denote a statistically significant difference (P 	 .05)
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activation of NO production through gene transfer of
eNOS10 and oral administration of the NO precursor L-
arginine.11 It is suggested that NOmay function as amodular
of VSMC mitogenesis and proliferation, through a cGMP-
mediatedmechanism.27 Taken together, these results suggest
that the oral administration of celiprolol may reduce intimal
thickening of the autogenous vein graft through an increase in
the function of endothelium-derived NO.
At least two possible mechanisms are considered to
account for the enhancement of NO function by celiprolol:
(1) reduction of the superoxide production and/or (2)
increase in eNOS expression. It was recently found that
celiprolol inhibits NAD(P)H oxidase p22phox, p47phox,
gp91phox, and nox1 expression.28 Huynh et al29 reported
superoxide dismutase decreased intimal hyperplasia in vein
grafts. Furthermore, celiprolol reduces superoxide anion
Fig 6. Effects of celiprolol on eNOS expression in endothelial
layer of vein graft from rabbits. A, Immunofluorescence against
eNOS can be seen in endothelial layers of two groups.B, Summary
of the effect of celiprolol on eNOS expression. As for fluorescence
intensities (arbitrary units), there are no significant differences
between the control and the celiprolol groups. The mean of data
from four different sections (from each animal) with SEM, P .48
vs control.production in essential hypertensive patients.12We demon-strated that in vein grafts, celiprolol strongly inhibited the
superoxide production in endothelial cells, but did not
modify the expression of eNOS. It is known that superox-
ide anions cause rapid-breakdown of nitric oxide forming
peroxynitrites. These results suggest that chronic adminis-
tration of celiprolol may inhibit the superoxide production
in endothelial cells and then may increase the endothelium-
derived NO function.
CONCLUSION
Our present study clearly demonstrates that chronic
administration of celiprolol induces both the suppression of
intimal hyperplasia development in the vein graft through
inhibition of cell proliferative activity and the enhancement
of nitric oxide function by reducing superoxide production.
This novel findingmay facilitate the clinical use of celiprolol
in postoperative patients to prevent late graft failure after
bypass grafting.
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